NCT05295355View on ClinicalTrials.gov

Effect of Tiotropium Bromide Combined With Odaterol on Small Airway Remodeling in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease

NAUnknownINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

September 30, 2024

Study Completion Date

March 31, 2025

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Tiotropium Bromide Combined With Odaterol

2 puffs once daily at the same time of the day for 52 week

Trial Locations (1)

510000

RECRUITING

Guangzhou Institute of Respiratory Diseases, Guangzhou

Sponsors

Collaborators (1)

Boehringer Ingelheim
All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

Guangzhou Institute of Respiratory Disease

OTHER

NCT05295355 - Effect of Tiotropium Bromide Combined With Odaterol on Small Airway Remodeling in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter